Is patella facet arthritis a contraindication to unicompartmental knee arthroplasty: Current concepts.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] Conflict of interest statement: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Adolph Lombardi, Jr., MD reports a relationship with Zimmer Biomet that includes: consulting or advisory. Adolph Lombardi, Jr., MD (JIS Research Institute) reports a relationship with Total Joint Orthopedics that includes: consulting or advisory. Adolph Lombardi, Jr., MD (JIS Research Institute) reports a relationship with Firstkind that includes: funding grants. Adolph Lombardi, Jr., MD reports a relationship with Parvizi Surgical Innovations Research Institute that includes: equity or stocks and funding grants. Adolph Lombardi, Jr., MD (JIS Research Institute) reports a relationship with Recovery Rx that includes: funding grants. Adolph Lombardi, Jr., MD (JIS Research Institute) reports a relationship with SPR Therapeutics Inc that includes: funding grants. Adolph Lombardi, Jr., MD (JIS Research Institute) reports a relationship with Prescribe Fit that includes: equity or stocks and funding grants. Adolph Lombardi, Jr., MD reports a relationship with Smith and Nephew Inc that includes: funding grants. Adolph Lombardi, Jr., MD reports a relationship with SI-BONE Inc that includes: funding grants. Adolph Lombardi, Jr., MD reports a relationship with JIS Ventures that includes: equity or stocks. Adolph Lombardi, Jr., MD reports a relationship with Joint Development Corporation that includes: equity or stocks. Adolph Lombardi, Jr., MD reports a relationship with Operation Walk USA that includes: board membership. Adolph Lombardi, Jr., MD reports a relationship with Central Ohio Orthopaedic Management Company that includes: board membership. Adolph Lombardi, Jr. MD reports a relationship with Current Concepts in Joint Replacement that includes: board membership. Keith Berend, MD reports a relationship with Medacta USA INC that includes: speaking and lecture fees. Keith Berend, MD reports a relationship with Smith and Nephew Inc that includes: funding grants and speaking and lecture fees. Keith Berend, MD (JIS Research Institute) reports a relationship with Zimmer Biomet that includes: funding grants. Keith Berend (JIS Research Institute) reports a relationship with Total Joint Orthopedics that includes: funding grants. Keith Berend, MD (JIS Research Institute) reports a relationship with Firstkind that includes: funding grants. Keith Berend, MD (JIS Research Institute) reports a relationship with Parvizi Surgical Innovations Research Institute that includes: equity or stocks and funding grants. Keith Berend, MD (JIS Research Institute) reports a relationship with Recovery Rx that includes: funding grants. Keith Berend, MD (JIS Research Institute) reports a relationship with Prescribe Fit that includes: equity or stocks and funding grants. Keith Berend, MD reports a relationship with SPR Therapeutics that includes: funding grants. Keith Berend, MD (JIS Research Institute) reports a relationship with SI-BONE Inc that includes: funding grants. Keith Berend, MD reports a relationship with JIS Ventures that includes: equity or stocks. Keith Berend, MD reports a relationship with Joint Development Corporation that includes: equity or stocks. Adolph Lombardi, Jr., MD has patent with royalties paid to Zimmer Biomet. Adolph Lombardi, Jr., MD has patent with royalties paid to Innomed. Publications Editorial Boards (Adolph Lombardi, Jr., MD): Journal of Arthroplasty; Journal of Bone and Joint Surgery; Clinical Orthopaedics and Related Research; Journal of the American Academy of Orthopaedic Surgeons; Journal of Orthopaedics and Traumatology; Surgical Technology International; The Knee; The Bone & Joint Journal Publications Editorial Boards (Keith Berend, MD): Journal of Arthroplasty; Reconstructive Review. Todd Bertrand, MD, MBA; Patricia Melvin, MD, MBS have no known competing financial interests or personal relationships to declare that could have appeared to influence the work reported in this paper. 19. Acta Biomed. 2023 Dec 5;94(6):e2023240. doi: 10.23750/abm.v94i6.15006. Outcome of simultaneous bi-unicompartmental knee arthroplasty: a systematic review. Akkawi I(1), Draghetti M(2), Zmerly H(3). Author information: (1)Villa Erbosa Hospital 50/2, 40129, Bologna, Italy. i.akkawi@libero.it. (2)Orthopaedics and Traumatology Unit, Villa Erbosa Hospital, Bologna, Italy. mauriziodraghetti@gmail.it. (3)Orthopaedics and Traumatology Unit, Villa Erbosa Hospital, Bologna, Italy. hzmerly@hotmail.it. BACKGROUND AND AIM: Simultaneous medial and lateral tibiofemoral osteoarthritis (OA) could be treated with bi-unicompartmental knee arthroplasty (Bi-UKA) as an alternative to total knee arthroplasty (TKA). The present systematic review aims to assess if simultaneous Bi-UKA is a feasible option for treating medial and lateral tibiofemoral OA. MATERIALS AND METHODS: A comprehensive search of PubMed, MEDLINE, Cochrane Library, and Google Scholar was performed to find studies that reported on the outcome of simultaneous Bi-UKA for both medial and lateral tibiofemoral OA. RESULTS: Seven studies were considered eligible for inclusion in the present systematic review. Intraoperative fractures occurred 8 times. Overall, there were 22 revisions of the prosthetic components for any reason with a survival rate that ranged from 83 to 100%. Of these, 16 revisions were for the aseptic loosening of the prosthetic components. Out of 302 surgeries, three were revised due to symptomatic OA progression in the patello-femoral joint. All clinical scores improved at the latest follow-up compared to preoperative values. Moreover, there were no differences in clinical scores of Bi-UKA compared to unicompartmental knee arthroplasty (UKA), or medial UKA plus patello-femoral prosthesis. Whereas, compared to TKA, Bi-UKA patients had comparable or superior scores. Finally, the Bi-UKA group had a significantly shorter hospital stay compared to the TKA group. CONCLUSIONS: The use of simultaneous Bi-UKA is a valid option to address bicompartmental knee OA in selected patients with low intraoperative fracture rate, low revision rate, satisfactory clinical outcome, and fast recovery. DOI: 10.23750/abm.v94i6.15006 PMCID: PMC10734244